ANBENITAMAB REPODATECAN ASPARAGINE MODIFICATION
UNII AZ4UZN9LF2

Substance Identification & Data

This profile provides standardized clinical and technical data for Anbenitamab Repodatecan Asparagine Modification, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AZ4UZN9LF2.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

AZ4UZN9LF2

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ANBENITAMAB REPODATECAN ASPARAGINE MODIFICATION

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C220H282F2N34O86

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

JCITXTRXWKMHKE-UAWMYEJOSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

172866781

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(C(N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]2[C@@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]3OC[C@@H]4[C@@H](O[C@@H]5[C@@H](O[C@H]6[C@H](NC(=O)C)[C@@H](O)[C@H](O[C@H]7[C@H](NC(=O)Cn8c-9c(-c%10c(N(C(CCC(NCCOCCOCCOCCOCCC(NCC(NCC(N[C@@H](Cc%11ccccc%11)C(NCC(NCOCC(N[C@@H]%12c%13c%14c(nc%15c%13c(c(C)c(F)c%15)CC%12)-c%16n(c(=O)c%17c(c%16)[C@](CC)(O)C(=O)OC%17)C%14)=O)=O)=O)=O)=O)=O)=O)=O)Cc%18c9cccc%18)cccc%10)nn8)[C@@H](O)[C@@H](O)[C@@H](CO)O7)[C@@H](CO)O6)[C@@H](O)[C@H](O)[C@@H](CO)O5)[C@H](O)[C@H](O)[C@H](O[C@H]%19[C@H](O)[C@@H](NC(C)=O)[C@H](O[C@H]%20[C@H](O)[C@@H](NC(=O)C)[C@H](NC(C[C@H](N)C(=O)O)=O)O[C@@H]%20CO[C@@H]%21O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]%21O)O[C@@H]%19CO)O4)[C@H](NC(C)=O)[C@H]2O)=O)n%22nnc%23-c%24ccccc%24CN(c%25ccccc%25-c%23%22)C(=O)CCC(=O)NCCOCCOCCOCCOCCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)NCC(=O)NCOCC(=O)N[C@H]%26CCc%27c(c(cc%28c%27c%26c%29Cn%30c(c%31COC(=O)[C@](O)(CC)c%31cc%30-c%29n%28)=O)F)C)Cc%32ccccc%32

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Anbenitamab Repodatecan Asparagine Modification. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

ANBENITAMAB REPODATECAN ASPARAGINE MODIFICATION

External Clinical & Regulatory Resources

Previous UNIIAZ4Q643U3D

Next UNIIAZ5DFQ2E3F